We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGI icon
676
Angi Inc
ANGI
$219M
$1.24M 0.01%
180,484
-109,455
-38% -$1.1M
SGHT icon
677
Sight Sciences
SGHT
$256M
$1.24M 0.01%
327,912
+313,866
+2,235% +$1.69M
EFSC icon
678
Enterprise Financial Services Corp
EFSC
$2.38B
$1.22M 0.01%
22,460
+2,745
+14% +$155K
BJRI icon
679
BJ's Restaurants
BJRI
$1.37B
$1.2M 0.01%
34,163
+14,848
+77% +$594K
NP
680
Neptune Insurance Holdings
NP
$4.1B
$1.19M 0.01%
+48,994
New +$1.13M
FOA icon
681
Finance of America Companies
FOA
$200M
$1.17M ﹤0.01%
70,679
+60,813
+616% +$1.26M
ASO icon
682
Academy Sports + Outdoors
ASO
$2.92B
$1.16M ﹤0.01%
20,559
FLYW icon
683
Flywire
FLYW
$1.99B
$1.15M ﹤0.01%
99,101
-505,444
-84% -$6.36M
BBNX
684
Beta Bionics
BBNX
$719M
$1.15M ﹤0.01%
114,719
+77,345
+207% +$1.14M
MEI icon
685
Methode Electronics
MEI
$569M
$1.14M ﹤0.01%
+207,293
New +$1.52M
CTKB icon
686
Cytek Biosciences
CTKB
$589M
$1.12M ﹤0.01%
257,292
-6,885
-3% -$32.5K
SNBR
687
DELISTED
Sleep Number
SNBR
$1.12M ﹤0.01%
624,287
+3,988
+0.6% +$30K
ATLC icon
688
Atlanticus Holdings
ATLC
$1.45B
$1.1M ﹤0.01%
20,912
-5,181
-20% -$290K
MITT
689
TPG Mortgage Investment Trust
MITT
$231M
$1.08M ﹤0.01%
148,199
+56,827
+62% +$470K
OIS icon
690
Oil States International
OIS
$522M
$1.08M ﹤0.01%
92,804
+11,544
+14% +$119K
HIW icon
691
Highwoods Properties
HIW
$3.61B
$1.08M ﹤0.01%
50,294
-1,964
-4% -$47.2K
ZYME icon
692
Zymeworks
ZYME
$1.7B
$1.07M ﹤0.01%
+42,786
New +$1.01M
LENZ
693
LENZ Therapeutics
LENZ
$158M
$1.07M ﹤0.01%
117,011
-153,908
-57% -$2.16M
BOOT icon
694
Boot Barn
BOOT
$4.48B
$1.07M ﹤0.01%
7,297
-104
-1% -$18.9K
WHD icon
695
Cactus
WHD
$3.85B
$1.06M ﹤0.01%
22,411
HDSN
696
Hudson Technologies
HDSN
$266M
$1.05M ﹤0.01%
178,933
+19,205
+12% +$132K
DXC icon
697
DXC Technology
DXC
$1.5B
$1.05M ﹤0.01%
83,533
-38,357
-31% -$515K
AMPY icon
698
Amplify Energy
AMPY
$171M
$1.05M ﹤0.01%
+167,653
New +$912K
WS icon
699
Worthington Steel
WS
$1.8B
$1.05M ﹤0.01%
34,451
-73,349
-68% -$2.84M
DOX icon
700
Amdocs
DOX
$5.4B
$1.01M ﹤0.01%
15,552

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.